MAKOWER JOSHUA
Insider CIK 1235952 · MRKR 10% owner · AKAO 10% owner · AVEO 10% owner · CASC 10% owner · ARDX 10% owner · GNCA 10% owner · RGLS 10% owner · TRVI 10% owner · MTCR 10% owner · RPHM 10% owner · BHG 10% owner · INZY 10% owner · NITE 10% owner · EAR Director, 10% owner · AKUS 10% owner · DM 10% owner · MIRM 10% owner · NKTK 10% owner · GLUE 10% owner · ABIO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EAR Eargo, Inc. | A Award deriv | 2022-10-12 | 2022-10-14 | 74,074 | — | $0 | 74,074 | SEC↗ |
| EAR Eargo, Inc. | A Award deriv | 2022-08-23 | 2022-08-25 | 74,805 | — | $0 | 74,805 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,361,912 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 11,500,000 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 9,588,725 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,109,284 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 15,619,807 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 8,901,166 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 6,516,356 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,954,906 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,448,856 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,164,748 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 12,712,399 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 4,980,687 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,224,428 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 2,715,968 | — | $0 | 2,715,968 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | P Buy | 2021-06-28 | 2021-06-30 | 1,050,000 | $19.00 | $19.95M | 7,692,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 3,257,328 | — | $0 | 5,973,296 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 669,002 | — | $0 | 6,642,298 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 38,137,197 | — | $0 | 44,001,915 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 5,864,718 | — | $0 | 5,864,718 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 3,494,244 | — | $0 | 3,494,244 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 3,327,852 | — | $0 | 107,041,764 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 19,549,068 | — | $0 | 103,713,912 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 26,703,498 | — | $0 | 84,164,844 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 10,601,925 | — | $0 | 57,461,346 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy | 2021-06-28 | 2021-06-30 | 1,694,444 | $18.00 | $30.50M | 23,983,073 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 7,346,568 | — | $0 | 22,288,629 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 14,942,061 | — | $0 | 14,942,061 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy | 2021-06-28 | 2021-06-30 | 250,000 | $18.00 | $4.50M | 47,925,199 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 3,673,284 | — | $0 | 47,675,199 | SEC↗ |
| DM Desktop Metal, Inc. | J Other | 2021-06-08 | 2021-06-10 | 9,000,000 | — | $0 | 19,263,413 | SEC↗ |
| DM Desktop Metal, Inc. | J Other | 2021-06-08 | 2021-06-10 | 135,000 | — | $0 | 135,000 | SEC↗ |
| DM Desktop Metal, Inc. | J Other | 2021-06-08 | 2021-06-10 | 135,000 | — | $0 | 0 | SEC↗ |
| DM Desktop Metal, Inc. | J Other | 2021-06-08 | 2021-06-10 | 2,285 | — | $0 | 2,285 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-24 | 2021-05-26 | 30,000 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-24 | 2021-05-26 | 508 | — | $0 | 508 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-24 | 2021-05-26 | 2,000,000 | — | $0 | 4,520,019 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-24 | 2021-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion deriv | 2021-04-13 | 2021-04-15 | 8,904,280 | — | $0 | 0 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion deriv | 2021-04-13 | 2021-04-15 | 9,526,652 | — | $0 | 0 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | P Buy | 2021-04-13 | 2021-04-15 | 666,666 | $15.00 | $10.00M | 4,785,494 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion | 2021-04-13 | 2021-04-15 | 1,989,872 | — | $0 | 4,118,828 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion | 2021-04-13 | 2021-04-15 | 2,128,956 | — | $0 | 2,128,956 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2020-12-04 | 2020-12-07 | 5,239,254 | $0.13 | $681.1K | 5,239,254 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2020-12-04 | 2020-12-07 | 258,707 | $6.22 | $1.61M | 258,707 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2020-12-04 | 2020-12-07 | 4,398,602 | $0.62 | $2.73M | 6,451,056 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 1,274,929 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 546,532 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 762,959 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 560,789 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 1,433,459 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 791,214 | — | $0 | 4,076,284 | SEC↗ |
| EAR Eargo, Inc. | P Buy | 2020-10-20 | 2020-10-22 | 311,111 | $18.00 | $5.60M | 6,520,017 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 1,858,716 | — | $0 | 1,858,716 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 699,163 | — | $0 | 4,775,447 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 1,433,459 | — | $0 | 6,208,906 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 1,426,354 | — | $0 | 3,285,070 | SEC↗ |
| EAR Eargo, Inc. | A Award deriv | 2020-10-15 | 2020-10-19 | 6,666 | — | $0 | 6,666 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 332,964 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 1,958,333 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 769,230 | $13.00 | $10.00M | 3,060,527 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 332,964 | — | $0 | 2,291,297 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 1,958,333 | — | $0 | 1,958,333 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 250,000 | $16.00 | $4.00M | 2,437,689 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 187,156 | — | $0 | 2,187,689 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 2,000,533 | — | $0 | 2,000,533 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-25 | 2020-07-28 | 2,000,533 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-25 | 2020-07-28 | 187,156 | — | $0 | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| NKTK Nkarta, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-16 | 522,639 | — | $0 | 0 | SEC↗ |
| NKTK Nkarta, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-16 | 1,712,810 | — | $0 | 0 | SEC↗ |
| NKTK Nkarta, Inc. | C Conversion | 2020-07-14 | 2020-07-16 | 522,639 | — | $0 | 522,639 | SEC↗ |
| NKTK Nkarta, Inc. | P Buy | 2020-07-14 | 2020-07-16 | 666,666 | $18.00 | $12.00M | 2,902,115 | SEC↗ |
| NKTK Nkarta, Inc. | C Conversion | 2020-07-14 | 2020-07-16 | 1,712,810 | — | $0 | 2,235,449 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,992,238 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,199,976 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 513,758 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,199,976 | — | $0 | 3,705,972 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,992,238 | — | $0 | 2,505,996 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-01 | 588,235 | $17.00 | $10.00M | 4,294,207 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 513,758 | — | $0 | 513,758 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | P Buy | 2020-06-19 | 2020-06-22 | 1,428,571 | $5.25 | $7.50M | 3,952,958 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | X Exercise deriv | 2020-04-03 | 2020-04-13 | 1,500,000 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | X Exercise | 2020-04-03 | 2020-04-13 | 1,500,000 | — | $0 | 5,938,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2020-04-03 | 2020-04-13 | 564 | $2.66 | $1.5K | 5,937,998 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 900,900 | $6.66 | $6.00M | 900,900 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 9,009,000 | $0.13 | $1.17M | 9,009,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2019-12-09 | 2019-12-09 | 400,000 | $6.25 | $2.50M | 3,482,186 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 29,889,945 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 450,000 | $15.00 | $6.75M | 4,186,243 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 3,736,243 | — | $0 | 3,736,243 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer | 2019-06-07 | 2019-06-07 | 6,662,532 | $25.50 | $169.89M | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 17,099,315 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 1,938,562 | — | $0 | 1,938,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,500,000 | $10.00 | $15.00M | 4,438,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,000,000 | $10.00 | $10.00M | 2,938,562 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 3,703,704 | $0.13 | $481.5K | 3,703,704 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 256,700 | $10.80 | $2.77M | 256,700 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2019-05-07 | 2019-05-09 | 1,136,704 | $1.08 | $1.23M | 2,052,454 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy deriv | 2019-04-08 | 2019-04-08 | 4,347,827 | $0.01 | $43.5K | 4,347,827 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2019-04-08 | 2019-04-08 | 4,347,827 | $1.14 | $4.96M | 25,243,865 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-21 | 2018-12-21 | 300,000 | $1.49 | $447.0K | 20,896,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-20 | 2018-12-21 | 200,000 | $1.63 | $326.0K | 20,596,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-11 | 2018-12-12 | 61,200 | $1.98 | $121.2K | 20,396,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-10 | 2018-12-10 | 26,000 | $1.98 | $51.5K | 20,334,838 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-07 | 2018-12-10 | 117,100 | $1.98 | $231.9K | 20,308,838 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-06 | 2018-12-10 | 27,300 | $1.99 | $54.3K | 20,191,738 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-30 | 2018-11-30 | 71,900 | $1.98 | $142.4K | 20,164,438 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-28 | 2018-11-30 | 24,500 | $1.99 | $48.8K | 20,092,538 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-20 | 2018-11-21 | 170,000 | $1.98 | $336.6K | 20,068,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-19 | 2018-11-19 | 510,000 | $1.88 | $958.8K | 19,898,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-16 | 2018-11-19 | 350,000 | $1.86 | $651.0K | 19,388,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-15 | 2018-11-19 | 340,000 | $1.86 | $632.4K | 19,038,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-08-21 | 2018-08-22 | 663,716 | $2.26 | $1.50M | 18,698,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-07-19 | 2018-07-20 | 50,600 | $2.00 | $101.2K | 18,034,322 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-07-18 | 2018-07-20 | 200,000 | $1.95 | $390.0K | 17,983,722 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-06-28 | 2018-06-28 | 187,130 | $2.10 | $393.0K | 17,783,722 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-06-27 | 2018-06-28 | 5,295 | $2.15 | $11.4K | 17,596,592 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-30 | 2018-05-30 | 275 | $2.15 | $591 | 17,591,297 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-05-25 | 2018-05-30 | 416,667 | $4.00 | $1.67M | 3,082,186 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-05-25 | 2018-05-30 | 416,666 | $4.00 | $1.67M | 3,082,186 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-21 | 2018-05-21 | 32,200 | $2.14 | $68.9K | 17,591,022 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-18 | 2018-05-21 | 20,100 | $2.14 | $43.0K | 17,558,822 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-17 | 2018-05-21 | 184,179 | $2.13 | $392.3K | 17,538,722 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-05-08 | 2018-05-10 | 70,873 | $2.13 | $151.0K | 17,354,543 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-04-10 | 2018-04-10 | 203,200 | $2.46 | $499.9K | 17,283,670 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-04-09 | 2018-04-10 | 32,100 | $2.43 | $78.0K | 17,080,470 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-04-06 | 2018-04-10 | 685,676 | $2.24 | $1.54M | 17,048,370 | SEC↗ |
| CASC Cascadian Therapeutics, In | U Tender | 2018-03-09 | 2018-03-13 | 10,882,574 | — | $0 | 0 | SEC↗ |
| ABIO ARCA biopharma, Inc. | S Sale | 2018-02-26 | 2018-02-27 | 1,460,209 | $0.50 | $730.1K | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | C Conversion deriv | 2018-02-20 | 2018-02-22 | 1,818,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | C Conversion | 2018-02-20 | 2018-02-22 | 1,818,000 | $3.30 | $6.00M | 10,882,574 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2017-03-28 | 2017-03-29 | 6,000,000 | $0.50 | $3.00M | 16,362,694 | SEC↗ |
| AKAO Achaogen Inc | P Buy | 2016-12-19 | 2016-12-19 | 500,000 | $13.50 | $6.75M | 5,215,128 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2016-07-18 | 2016-07-20 | 763,651 | $8.73 | $6.67M | 2,665,520 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2016-07-18 | 2016-07-20 | 763,650 | $8.73 | $6.67M | 2,665,519 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2016-01-13 | 2016-01-14 | 500,000 | $10.00 | $5.00M | 1,901,869 | SEC↗ |
| ARDX ARDELYX, INC. | P Buy | 2016-01-13 | 2016-01-14 | 500,000 | $10.00 | $5.00M | 1,901,869 | SEC↗ |